[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Alcohol Addiction Therapeutics Market Research Report 2024(Status and Outlook)

August 2024 | 144 pages | ID: GD199682AC87EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

This report provides a deep insight into the global Alcohol Addiction Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alcohol Addiction Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alcohol Addiction Therapeutics market in any manner.

Global Alcohol Addiction Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca Plc

BioCorRx Inc

Bionex Pharmaceuticals LLC

Cerecor Inc

Chronos Therapeutics Ltd

Corcept Therapeutics Inc

Curemark LLC

Eli Lilly and Company

Ethypharm SA

H. Lundbeck A/S

Heptares Therapeutics Ltd

Indivior Plc

Kinnov Therapeutics SAS

Kyorin Pharmaceutical Co Ltd

Lohocla Research Corp

Montisera Ltd

Omeros Corp

Opiant Pharmaceuticals Inc

Market Segmentation (by Type)

CM-1212

CTDP-002

A-705253

ABT-436

ADX-71441

Others

Market Segmentation (by Application)

Hospital

Clinic

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Alcohol Addiction Therapeutics Market
  • Overview of the regional outlook of the Alcohol Addiction Therapeutics Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alcohol Addiction Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Alcohol Addiction Therapeutics
1.2 Key Market Segments
  1.2.1 Alcohol Addiction Therapeutics Segment by Type
  1.2.2 Alcohol Addiction Therapeutics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ALCOHOL ADDICTION THERAPEUTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Alcohol Addiction Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Alcohol Addiction Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ALCOHOL ADDICTION THERAPEUTICS MARKET COMPETITIVE LANDSCAPE

3.1 Global Alcohol Addiction Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alcohol Addiction Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alcohol Addiction Therapeutics Sales Sites, Area Served, Product Type
3.6 Alcohol Addiction Therapeutics Market Competitive Situation and Trends
  3.6.1 Alcohol Addiction Therapeutics Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Alcohol Addiction Therapeutics Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ALCOHOL ADDICTION THERAPEUTICS INDUSTRY CHAIN ANALYSIS

4.1 Alcohol Addiction Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ALCOHOL ADDICTION THERAPEUTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ALCOHOL ADDICTION THERAPEUTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alcohol Addiction Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Alcohol Addiction Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Alcohol Addiction Therapeutics Price by Type (2019-2024)

7 ALCOHOL ADDICTION THERAPEUTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alcohol Addiction Therapeutics Market Sales by Application (2019-2024)
7.3 Global Alcohol Addiction Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Alcohol Addiction Therapeutics Sales Growth Rate by Application (2019-2024)

8 ALCOHOL ADDICTION THERAPEUTICS MARKET SEGMENTATION BY REGION

8.1 Global Alcohol Addiction Therapeutics Sales by Region
  8.1.1 Global Alcohol Addiction Therapeutics Sales by Region
  8.1.2 Global Alcohol Addiction Therapeutics Sales Market Share by Region
8.2 North America
  8.2.1 North America Alcohol Addiction Therapeutics Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Alcohol Addiction Therapeutics Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Alcohol Addiction Therapeutics Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Alcohol Addiction Therapeutics Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Alcohol Addiction Therapeutics Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 AstraZeneca Plc
  9.1.1 AstraZeneca Plc Alcohol Addiction Therapeutics Basic Information
  9.1.2 AstraZeneca Plc Alcohol Addiction Therapeutics Product Overview
  9.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Product Market Performance
  9.1.4 AstraZeneca Plc Business Overview
  9.1.5 AstraZeneca Plc Alcohol Addiction Therapeutics SWOT Analysis
  9.1.6 AstraZeneca Plc Recent Developments
9.2 BioCorRx Inc
  9.2.1 BioCorRx Inc Alcohol Addiction Therapeutics Basic Information
  9.2.2 BioCorRx Inc Alcohol Addiction Therapeutics Product Overview
  9.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Product Market Performance
  9.2.4 BioCorRx Inc Business Overview
  9.2.5 BioCorRx Inc Alcohol Addiction Therapeutics SWOT Analysis
  9.2.6 BioCorRx Inc Recent Developments
9.3 Bionex Pharmaceuticals LLC
  9.3.1 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Basic Information
  9.3.2 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product Overview
  9.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product Market Performance
  9.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics SWOT Analysis
  9.3.5 Bionex Pharmaceuticals LLC Business Overview
  9.3.6 Bionex Pharmaceuticals LLC Recent Developments
9.4 Cerecor Inc
  9.4.1 Cerecor Inc Alcohol Addiction Therapeutics Basic Information
  9.4.2 Cerecor Inc Alcohol Addiction Therapeutics Product Overview
  9.4.3 Cerecor Inc Alcohol Addiction Therapeutics Product Market Performance
  9.4.4 Cerecor Inc Business Overview
  9.4.5 Cerecor Inc Recent Developments
9.5 Chronos Therapeutics Ltd
  9.5.1 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Basic Information
  9.5.2 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product Overview
  9.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product Market Performance
  9.5.4 Chronos Therapeutics Ltd Business Overview
  9.5.5 Chronos Therapeutics Ltd Recent Developments
9.6 Corcept Therapeutics Inc
  9.6.1 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Basic Information
  9.6.2 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product Overview
  9.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product Market Performance
  9.6.4 Corcept Therapeutics Inc Business Overview
  9.6.5 Corcept Therapeutics Inc Recent Developments
9.7 Curemark LLC
  9.7.1 Curemark LLC Alcohol Addiction Therapeutics Basic Information
  9.7.2 Curemark LLC Alcohol Addiction Therapeutics Product Overview
  9.7.3 Curemark LLC Alcohol Addiction Therapeutics Product Market Performance
  9.7.4 Curemark LLC Business Overview
  9.7.5 Curemark LLC Recent Developments
9.8 Eli Lilly and Company
  9.8.1 Eli Lilly and Company Alcohol Addiction Therapeutics Basic Information
  9.8.2 Eli Lilly and Company Alcohol Addiction Therapeutics Product Overview
  9.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Product Market Performance
  9.8.4 Eli Lilly and Company Business Overview
  9.8.5 Eli Lilly and Company Recent Developments
9.9 Ethypharm SA
  9.9.1 Ethypharm SA Alcohol Addiction Therapeutics Basic Information
  9.9.2 Ethypharm SA Alcohol Addiction Therapeutics Product Overview
  9.9.3 Ethypharm SA Alcohol Addiction Therapeutics Product Market Performance
  9.9.4 Ethypharm SA Business Overview
  9.9.5 Ethypharm SA Recent Developments
9.10 H. Lundbeck A/S
  9.10.1 H. Lundbeck A/S Alcohol Addiction Therapeutics Basic Information
  9.10.2 H. Lundbeck A/S Alcohol Addiction Therapeutics Product Overview
  9.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Product Market Performance
  9.10.4 H. Lundbeck A/S Business Overview
  9.10.5 H. Lundbeck A/S Recent Developments
9.11 Heptares Therapeutics Ltd
  9.11.1 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Basic Information
  9.11.2 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product Overview
  9.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product Market Performance
  9.11.4 Heptares Therapeutics Ltd Business Overview
  9.11.5 Heptares Therapeutics Ltd Recent Developments
9.12 Indivior Plc
  9.12.1 Indivior Plc Alcohol Addiction Therapeutics Basic Information
  9.12.2 Indivior Plc Alcohol Addiction Therapeutics Product Overview
  9.12.3 Indivior Plc Alcohol Addiction Therapeutics Product Market Performance
  9.12.4 Indivior Plc Business Overview
  9.12.5 Indivior Plc Recent Developments
9.13 Kinnov Therapeutics SAS
  9.13.1 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Basic Information
  9.13.2 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product Overview
  9.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product Market Performance
  9.13.4 Kinnov Therapeutics SAS Business Overview
  9.13.5 Kinnov Therapeutics SAS Recent Developments
9.14 Kyorin Pharmaceutical Co Ltd
  9.14.1 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Basic Information
  9.14.2 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product Overview
  9.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product Market Performance
  9.14.4 Kyorin Pharmaceutical Co Ltd Business Overview
  9.14.5 Kyorin Pharmaceutical Co Ltd Recent Developments
9.15 Lohocla Research Corp
  9.15.1 Lohocla Research Corp Alcohol Addiction Therapeutics Basic Information
  9.15.2 Lohocla Research Corp Alcohol Addiction Therapeutics Product Overview
  9.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Product Market Performance
  9.15.4 Lohocla Research Corp Business Overview
  9.15.5 Lohocla Research Corp Recent Developments
9.16 Montisera Ltd
  9.16.1 Montisera Ltd Alcohol Addiction Therapeutics Basic Information
  9.16.2 Montisera Ltd Alcohol Addiction Therapeutics Product Overview
  9.16.3 Montisera Ltd Alcohol Addiction Therapeutics Product Market Performance
  9.16.4 Montisera Ltd Business Overview
  9.16.5 Montisera Ltd Recent Developments
9.17 Omeros Corp
  9.17.1 Omeros Corp Alcohol Addiction Therapeutics Basic Information
  9.17.2 Omeros Corp Alcohol Addiction Therapeutics Product Overview
  9.17.3 Omeros Corp Alcohol Addiction Therapeutics Product Market Performance
  9.17.4 Omeros Corp Business Overview
  9.17.5 Omeros Corp Recent Developments
9.18 Opiant Pharmaceuticals Inc
  9.18.1 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Basic Information
  9.18.2 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product Overview
  9.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product Market Performance
  9.18.4 Opiant Pharmaceuticals Inc Business Overview
  9.18.5 Opiant Pharmaceuticals Inc Recent Developments

10 ALCOHOL ADDICTION THERAPEUTICS MARKET FORECAST BY REGION

10.1 Global Alcohol Addiction Therapeutics Market Size Forecast
10.2 Global Alcohol Addiction Therapeutics Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Alcohol Addiction Therapeutics Market Size Forecast by Country
  10.2.3 Asia Pacific Alcohol Addiction Therapeutics Market Size Forecast by Region
  10.2.4 South America Alcohol Addiction Therapeutics Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Alcohol Addiction Therapeutics by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Alcohol Addiction Therapeutics Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Alcohol Addiction Therapeutics by Type (2025-2030)
  11.1.2 Global Alcohol Addiction Therapeutics Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Alcohol Addiction Therapeutics by Type (2025-2030)
11.2 Global Alcohol Addiction Therapeutics Market Forecast by Application (2025-2030)
  11.2.1 Global Alcohol Addiction Therapeutics Sales (K Units) Forecast by Application
  11.2.2 Global Alcohol Addiction Therapeutics Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alcohol Addiction Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Alcohol Addiction Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Alcohol Addiction Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Alcohol Addiction Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Alcohol Addiction Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcohol Addiction Therapeutics as of 2022)
Table 10. Global Market Alcohol Addiction Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Alcohol Addiction Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Alcohol Addiction Therapeutics Product Type
Table 13. Global Alcohol Addiction Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Alcohol Addiction Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alcohol Addiction Therapeutics Market Challenges
Table 22. Global Alcohol Addiction Therapeutics Sales by Type (K Units)
Table 23. Global Alcohol Addiction Therapeutics Market Size by Type (M USD)
Table 24. Global Alcohol Addiction Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Alcohol Addiction Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Alcohol Addiction Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Alcohol Addiction Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Alcohol Addiction Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Alcohol Addiction Therapeutics Sales (K Units) by Application
Table 30. Global Alcohol Addiction Therapeutics Market Size by Application
Table 31. Global Alcohol Addiction Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Alcohol Addiction Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Alcohol Addiction Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Alcohol Addiction Therapeutics Market Share by Application (2019-2024)
Table 35. Global Alcohol Addiction Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Alcohol Addiction Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Alcohol Addiction Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Alcohol Addiction Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Alcohol Addiction Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Alcohol Addiction Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Alcohol Addiction Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Alcohol Addiction Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Plc Alcohol Addiction Therapeutics Basic Information
Table 44. AstraZeneca Plc Alcohol Addiction Therapeutics Product Overview
Table 45. AstraZeneca Plc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Plc Business Overview
Table 47. AstraZeneca Plc Alcohol Addiction Therapeutics SWOT Analysis
Table 48. AstraZeneca Plc Recent Developments
Table 49. BioCorRx Inc Alcohol Addiction Therapeutics Basic Information
Table 50. BioCorRx Inc Alcohol Addiction Therapeutics Product Overview
Table 51. BioCorRx Inc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. BioCorRx Inc Business Overview
Table 53. BioCorRx Inc Alcohol Addiction Therapeutics SWOT Analysis
Table 54. BioCorRx Inc Recent Developments
Table 55. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Basic Information
Table 56. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product Overview
Table 57. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics SWOT Analysis
Table 59. Bionex Pharmaceuticals LLC Business Overview
Table 60. Bionex Pharmaceuticals LLC Recent Developments
Table 61. Cerecor Inc Alcohol Addiction Therapeutics Basic Information
Table 62. Cerecor Inc Alcohol Addiction Therapeutics Product Overview
Table 63. Cerecor Inc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cerecor Inc Business Overview
Table 65. Cerecor Inc Recent Developments
Table 66. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Basic Information
Table 67. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product Overview
Table 68. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Chronos Therapeutics Ltd Business Overview
Table 70. Chronos Therapeutics Ltd Recent Developments
Table 71. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Basic Information
Table 72. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product Overview
Table 73. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Corcept Therapeutics Inc Business Overview
Table 75. Corcept Therapeutics Inc Recent Developments
Table 76. Curemark LLC Alcohol Addiction Therapeutics Basic Information
Table 77. Curemark LLC Alcohol Addiction Therapeutics Product Overview
Table 78. Curemark LLC Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Curemark LLC Business Overview
Table 80. Curemark LLC Recent Developments
Table 81. Eli Lilly and Company Alcohol Addiction Therapeutics Basic Information
Table 82. Eli Lilly and Company Alcohol Addiction Therapeutics Product Overview
Table 83. Eli Lilly and Company Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Recent Developments
Table 86. Ethypharm SA Alcohol Addiction Therapeutics Basic Information
Table 87. Ethypharm SA Alcohol Addiction Therapeutics Product Overview
Table 88. Ethypharm SA Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Ethypharm SA Business Overview
Table 90. Ethypharm SA Recent Developments
Table 91. H. Lundbeck A/S Alcohol Addiction Therapeutics Basic Information
Table 92. H. Lundbeck A/S Alcohol Addiction Therapeutics Product Overview
Table 93. H. Lundbeck A/S Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. H. Lundbeck A/S Business Overview
Table 95. H. Lundbeck A/S Recent Developments
Table 96. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Basic Information
Table 97. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product Overview
Table 98. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Heptares Therapeutics Ltd Business Overview
Table 100. Heptares Therapeutics Ltd Recent Developments
Table 101. Indivior Plc Alcohol Addiction Therapeutics Basic Information
Table 102. Indivior Plc Alcohol Addiction Therapeutics Product Overview
Table 103. Indivior Plc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Indivior Plc Business Overview
Table 105. Indivior Plc Recent Developments
Table 106. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Basic Information
Table 107. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product Overview
Table 108. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Kinnov Therapeutics SAS Business Overview
Table 110. Kinnov Therapeutics SAS Recent Developments
Table 111. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Basic Information
Table 112. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product Overview
Table 113. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Kyorin Pharmaceutical Co Ltd Business Overview
Table 115. Kyorin Pharmaceutical Co Ltd Recent Developments
Table 116. Lohocla Research Corp Alcohol Addiction Therapeutics Basic Information
Table 117. Lohocla Research Corp Alcohol Addiction Therapeutics Product Overview
Table 118. Lohocla Research Corp Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Lohocla Research Corp Business Overview
Table 120. Lohocla Research Corp Recent Developments
Table 121. Montisera Ltd Alcohol Addiction Therapeutics Basic Information
Table 122. Montisera Ltd Alcohol Addiction Therapeutics Product Overview
Table 123. Montisera Ltd Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Montisera Ltd Business Overview
Table 125. Montisera Ltd Recent Developments
Table 126. Omeros Corp Alcohol Addiction Therapeutics Basic Information
Table 127. Omeros Corp Alcohol Addiction Therapeutics Product Overview
Table 128. Omeros Corp Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Omeros Corp Business Overview
Table 130. Omeros Corp Recent Developments
Table 131. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Basic Information
Table 132. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product Overview
Table 133. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Opiant Pharmaceuticals Inc Business Overview
Table 135. Opiant Pharmaceuticals Inc Recent Developments
Table 136. Global Alcohol Addiction Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Alcohol Addiction Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Alcohol Addiction Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Alcohol Addiction Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Alcohol Addiction Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Alcohol Addiction Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Alcohol Addiction Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Alcohol Addiction Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Alcohol Addiction Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Alcohol Addiction Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Alcohol Addiction Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Alcohol Addiction Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Alcohol Addiction Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Alcohol Addiction Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Alcohol Addiction Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Alcohol Addiction Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Alcohol Addiction Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Alcohol Addiction Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alcohol Addiction Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Alcohol Addiction Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Alcohol Addiction Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alcohol Addiction Therapeutics Market Size by Country (M USD)
Figure 11. Alcohol Addiction Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Alcohol Addiction Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Alcohol Addiction Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Alcohol Addiction Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Alcohol Addiction Therapeutics Market Share by Type
Figure 18. Sales Market Share of Alcohol Addiction Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Alcohol Addiction Therapeutics by Type in 2023
Figure 20. Market Size Share of Alcohol Addiction Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Alcohol Addiction Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Alcohol Addiction Therapeutics Market Share by Application
Figure 24. Global Alcohol Addiction Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Alcohol Addiction Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Alcohol Addiction Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Alcohol Addiction Therapeutics Market Share by Application in 2023
Figure 28. Global Alcohol Addiction Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Alcohol Addiction Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Alcohol Addiction Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Alcohol Addiction Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Alcohol Addiction Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Alcohol Addiction Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Alcohol Addiction Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Alcohol Addiction Therapeutics Sales Market Share by Region in 2023
Figure 44. China Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Alcohol Addiction Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Alcohol Addiction Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Alcohol Addiction Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Alcohol Addiction Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Alcohol Addiction Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Alcohol Addiction Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Alcohol Addiction Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Alcohol Addiction Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Alcohol Addiction Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Alcohol Addiction Therapeutics Market Share Forecast by Application (2025-2030)


More Publications